Thursday, 25 Apr 2019

PsA/SpA

Datesort ascending Type Title Save
15 Jun 2018 News Increased Risk of Infection in Psoriasis and Psoriatic Arthritis
14 Jun 2018 Social RT @DrPetryna: #EULAR18 @RheumNow ABST thu0316 Danish PSA registry: After adjustment for BL risk factors men sustain TNFi efficacy better.…
14 Jun 2018 Social RT @DrPetryna: #EULAR18 @RheumNow ABST thu0297 CVRF higher in PSO, PsA & periph SpA w/o PSO comparing to gen pop but similar amongst the Dx…
14 Jun 2018 Social RT @DrPetryna: #EULAR18 @RheumNow ABST thu0308 Serum calprotectin correlates with US PD-positive synovitis in early PSA but not RA. Validat…
14 Jun 2018 Social RT @RonanTKavanagh: “In psoriatic arthritis the enthesophyte = Köbner phenomenon of the enthesis. Dr Schett. (paraphrased)#EULAR2018 @rheum…
14 Jun 2018 Social RT @RonanTKavanagh: In UK audit of Ps A patients 8.9 week delay before GP visit and then 5.4 to see rheumatologist. Coates (UK HQIP audit)…
14 Jun 2018 Social RT @RonanTKavanagh: Although disease may be less severe at baseline in Ps A than in RA patients they fare less well at 3 months compared to…
14 Jun 2018 Social RT @RonanTKavanagh: Great (free) Psoriatic arthritis outcome assessment tool (patient and physician inputs). Mentioned by Coates. #EULAR201…
14 Jun 2018 Social RT @RonanTKavanagh: Whole body MRI detected more enthesitis than clinical exam in 80% of patients in PsA. Conaghan. #EULAR2018 @RheumNow (d…
14 Jun 2018 Social RT @AlexSepriano: What #IL17i can do in patients with #AxialSpA. HOT session #EULAR2018 @sofiaramiro82 @EMEUNET https://t.co/5bNpKPyK0H
14 Jun 2018 ACR Video Dr. Olga Petryna EULAR 2018 - Serum Calprotectin in Behcet's and PsA Posters
14 Jun 2018 News Cardiovascular Risk Factors in Psoriasis, PsA and Seronegative SpA
13 Jun 2018 Social RT @DrPetryna: #EULAR18 @RheumNow ABST op0067 Increased Dickkopf-1 (DKK1)( a natural inhibitor of Wnt signalling pathway) associated with d…
13 Jun 2018 Social Lindstrom studied their Swedish AS registry and found that While the presence of Uveitis was assoc w/ better TNFi responses; all other comorbidities yielded lesser TNFi responses. #EULAR2018 @RheumNow OP0023 https://t.co/bltRC4khbL
13 Jun 2018 Social RT @DrPetryna: #EULAR18 @RheumNow ABST op0028 BCD-085, novel humanised monoclonal IL-17 Ab w/ genetically modified Fc- and CDR-regions sho…
02 Jun 2018 Social RheumNow Wk in Review is up. Good news for GPA and Renal transplant, Early RA challenges, Vaccinots and HPV and the risk of cancer in PsA. Check out the podcast https://t.co/nqif5yPBx9 or the website video https://t.co/bj6ar7ZlYT
31 May 2018 News MRI Imaging for Sacroiliitis Requires Bone Marrow Edema for Reliability
29 May 2018 Social UCB announces the FDA has approved Cimzia (certolizumab) for use in moderate to severe plaque psoriasis based on over 1000 pts in Phase 3 RCTs CIMPASI-1, CIMPASI-2 and CIMPACT and PASI75 of 75-82% at wk16 https://t.co/PYx15htd3Z
29 May 2018 Social Certolizumab is now FDA approved for use in Crohns disease, Rheumatoid arthritis, Ankylosing spondylitis, psoriatic arthritis and now Psoriasis.https://t.co/QVpmv7V9PI
29 May 2018 News Cancer Risk Raised in Psoriatic Arthritis